Stock CSPCY CSPC PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights CSPC Pharmaceutical Group Limited OTC Markets

Equities

CSPCY

US12591J2078

Market Closed - OTC Markets
Other stock markets
 03:58:03 2024-07-17 pm EDT 		5-day change 1st Jan Change
3.02 USD 0.00% Intraday chart for CSPC Pharmaceutical Group Limited -0.33% -18.16%
Jul. 12 CSPC Pharmaceutical Group's Respiratory Vaccine Gets NMPA's Nod for Clinical Trials MT
Jul. 12 China approves CSPC Pharma's RSV vaccine for clinical trials RE

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China approves CSPC Pharma's RSV vaccine for clinical trials
RE
CSPC Pharmaceutical Group Limited Obtains Approval from the National Medical Products Administration of the People's Republic of China to Conduct Clinical Trials in China
CI
CSPC Pharma's Renal Anemia Drug Gets Registration Approval in China
MT
CSPC Pharmaceutical Group Limited Obtains Drug Registration Approval Granted by the National Medical Products Administration of the People's Republic of China
CI
CSPC Pharmaceutical Group Limited Announces Enlonstobart Injection Obtains Conditional Marketing Approval
CI
CSPC Pharmaceutical Group Limited Announces Palbociclib Tablets Obtains Drug Registration Approval
CI
Global markets live: Bayer, FedEx, Nvidia, KKR, Verizon...
Our Logo
China approves CSPC Pharma mRNA cancer therapy for clinical trials
RE
CSPC Pharmaceutical Group Limited Obtains Approval from National Medical Products Administration of the People's Republic of China to Conduct Clinical Trials in China
CI
CSPC Pharmaceutical Group Limited commences an Equity Buyback for 1,189,609,173 shares, representing 10% of its issued share capital, under the authorization approved on May 28, 2024.
CI
CSPC Pharmaceutical Buys Back Further Shares
MT
CSPC Pharmaceutical Repurchases 7 Million Shares
MT
CSPC Pharmaceutical Trustee Repurchases Further Shares Under Award Scheme
MT
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic
RE
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
RE
Corbus Pharmaceuticals Reaches 2-Year High After Drug Results
DJ
CSPC Pharmaceutical’s Trustee Buys Back Further Shares
MT
CSPC Pharmaceutical Group Limited Receives Approval for Olaparib Tablets by the National Medical Products Administration of the People's Republic of China
CI
Final dividend
FA
CSPC Pharmaceutical Repurchases 3 Million Shares
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1093 Stock
  4. CSPCY Stock
  5. News CSPC Pharmaceutical Group Limited
  6. Highlights